Brief description of Drug and Cosmetics act and rules especially Chapter IV A

Searching the Web

Drugs and Cosmetics Act 1940 Chapter IV A detailed provisions India

Searching the Web

Drugs and Cosmetics Rules 1945 Chapter IVA provisions regulations

Reading Web Page

https://faolex.fao.org/docs/pdf/ind157230.pdf

Here is a structured overview of the Drugs and Cosmetics Act, 1940 and Rules, 1945, with special focus on Chapter IV-A:

Drugs and Cosmetics Act, 1940 - Overview

Enacted: 1940 | Governing Authority: Ministry of Health & Family Welfare, CDSCO
Primary Objective: To regulate the import, manufacture, distribution, and sale of drugs and cosmetics in India, ensuring they meet safety, efficacy, and quality standards.

Structure of the Act

ChapterSubject
Chapter IPreliminary - short title, extent, definitions
Chapter IIAdministrative bodies (Central/State Boards, Committees)
Chapter IIIImport of drugs and cosmetics
Chapter IVManufacture, sale and distribution of drugs and cosmetics
Chapter IV-AProvisions relating to Ayurvedic, Siddha and Unani drugs
Chapter VMiscellaneous (penalties, offences, powers)

Key Definitions (Section 3)

  • Drug: All medicines for internal/external use in humans or animals; substances for diagnosis, treatment, mitigation, or prevention of disease; substances intended to affect body structure/function; substances used in the manufacture of any drug.
  • Cosmetic: Any article intended for use on the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.
  • Manufacture: Includes any process of making, altering, finishing, packing, labelling, breaking up, or otherwise treating/adapting a drug with a view to its sale or distribution.
  • Misbranded drug: A drug whose label is false, misleading, or fails to carry required information.
  • Adulterated drug: A drug whose strength/quality/purity falls below or differs from prescribed standards.
  • Spurious drug: A drug substituted wholly or partly for another drug, or imitates another drug, or bears a false name.

Chapter IV - Manufacture, Sale and Distribution of Drugs and Cosmetics (Sections 16-33A)

Key provisions:
  • Section 16 - Standards of quality: Drugs must comply with standards in the Second Schedule; cosmetics with prescribed standards.
  • Section 17 - Misbranded drugs defined.
  • Section 17A - Adulterated drugs defined.
  • Section 17B - Spurious drugs defined.
  • Section 18 - Prohibition on manufacture/sale of substandard, misbranded, adulterated, spurious drugs, or without a valid licence.
  • Section 22 - Powers of Inspectors to enter, inspect, search, seize, and take samples.
  • Section 23 - Procedure for taking samples.
  • Section 25 - Reports of Government Analysts to be used as evidence in court.
  • Section 27 - Penalties for manufacture/sale of spurious/adulterated/misbranded drugs (imprisonment 1-3 years + fine for spurious; can extend to life imprisonment in cases causing death).
  • Section 33A - Chapter IV does not apply to Ayurvedic, Siddha or Unani drugs (they are governed by Chapter IV-A).

Chapter IV-A - Provisions Relating to Ayurvedic, Siddha and Unani (ASU) Drugs (Sections 33B to 33N)

This chapter was inserted by the Drugs and Cosmetics (Amendment) Act, 1964 and substantially amended in 1982, creating a dedicated regulatory framework for traditional medicine systems.

Section 33B - Application

Chapter IV-A applies exclusively to Ayurvedic, Siddha and Unani (ASU) drugs. The First Schedule of the Act lists the authoritative reference books (e.g., Ayurvedic Pharmacopoeia of India, Unani Pharmacopoeia) from which these drugs must be sourced/formulated.

Section 33C - Ayurvedic, Siddha and Unani Drugs Technical Advisory Board (ASUDTAB)

  • Constituted by the Central Government by Gazette notification.
  • Advises Central and State Governments on technical matters arising under the chapter.
  • Membership includes experts in Ayurveda, Siddha, Unani, modern medicine, and pharmacognosy.

Section 33D - ASU Drugs Consultative Committee

  • Facilitates uniformity of action by State Governments in administering Chapter IV-A.
  • Acts as a liaison between Central and State authorities.

Section 33E - Misbranded ASU Drugs

A drug is misbranded if:
  • It is so coloured, coated, powdered, or polished that damage is concealed.
  • It is made to appear better/of greater therapeutic value than it really is.
  • Its label is false or misleading.
  • It does not carry required statutory label information.

Section 33EE - Adulterated ASU Drugs

An ASU drug is adulterated if it contains any filthy, putrid, decomposed matter; is prepared/packed under insanitary conditions; contains any harmful or deleterious substance; or its strength/purity falls below prescribed standards.

Section 33EEA - Spurious ASU Drugs

An ASU drug is spurious if it is sold under the name of another drug, substituted with an inferior drug, or has its label falsely claiming origin from a particular manufacturer.

Section 33EEB - Regulation of Manufacture for Sale

  • No person shall manufacture an ASU drug for sale without a valid licence issued by the prescribed authority.
  • Exception: Vaidyas (Ayurvedic practitioners) and Hakims (Unani practitioners) who manufacture drugs solely for their own patients are exempted from the licensing requirement.
  • Small quantities prepared for examination, test, or analysis are also exempted.

Section 33EEC - Prohibition on Manufacture/Sale of Certain ASU Drugs

Prohibits the manufacture and sale of any ASU drug that is misbranded, adulterated, spurious, or does not conform to prescribed standards.

Section 33EED - Power of Central Government to Prohibit in Public Interest

  • The Central Government may, by Gazette notification, ban the manufacture, sale, or distribution of any ASU drug if it is satisfied that:
    • The drug poses a risk to human beings or animals, OR
    • The drug lacks the therapeutic value claimed for it.
  • This is a precautionary public interest power.

Section 33F - Government Analysts

  • Central or State Governments may appoint Government Analysts for ASU drugs.
  • Their reports serve as evidence in legal proceedings.

Section 33G - Inspectors

  • Governments appoint Inspectors specifically for ASU drugs.
  • They must possess prescribed qualifications (typically an Ayurvedic/Siddha/Unani degree or a B.Pharm in Ayurveda plus 5 years' experience in ASU drug manufacture/testing/enforcement).
  • Inspectors are deemed public servants under Section 21 IPC.

Section 33H - Application of Inspection Provisions

Sections 22, 23, 24 and 25 of Chapter IV (inspection, sampling, analysis, reports) are applied mutatis mutandis to ASU drugs under this chapter.

Section 33-I - Penalties

OffencePunishment
Manufacture/sale of spurious ASU drugUp to 3 years imprisonment + fine up to Rs. 50,000 or 3x value of drug (whichever is more)
Manufacture/sale in contravention of 33EED (public interest ban)Up to 3 years + fine up to Rs. 50,000 or 3x value
Any other contravention of Chapter IV-AUp to 6 months + fine not less than Rs. 10,000

Section 33J - Penalty for Subsequent Offences

Enhanced penalties apply for repeat offences.

Section 33K - Confiscation

Any ASU drug manufactured/sold in contravention of the chapter is liable to confiscation.

Section 33L - Application to Government Departments

The provisions (except 33K) apply equally to manufacture/sale by government departments.

Section 33M - Cognizance of Offences

No prosecution under Chapter IV-A shall be initiated by an Inspector except with prior sanction of the prescribed authority.

Drugs and Cosmetics Rules, 1945 - Chapter IVA Related Rules

The Rules operationalise Chapter IV-A. Key provisions include:
  • Schedule T: Requirements for factory premises, plant, equipment, and hygienic conditions for manufacture of ASU drugs (the ASU equivalent of GMP).
  • Schedule E(i): List of poisonous substances used in Ayurvedic, Siddha and Unani systems (e.g., certain heavy metals, plant toxins) requiring special handling.
  • Schedule A: Forms for licensing applications under Chapter IV-A.
  • Rule 162A: Qualifications of the State Drug Licensing Authority for ASU drugs - must hold an Ayurvedic/Siddha/Unani qualification (per CCIM Act 1970) or B.Pharm (Ayurveda) plus at least 5 years' experience in ASU drug manufacture, testing, or enforcement.
  • First Schedule of the Act: Lists authoritative books (Ayurvedic Pharmacopoeia of India, Siddha Pharmacopoeia, Unani Pharmacopoeia, etc.) to define what constitutes a standard ASU formulation.

Important Schedules Under the Rules (Overview)

ScheduleContent
Schedule AApplication forms for licences
Schedule BFees for drug testing/analysis
Schedule C & C(i)Biological and special products
Schedule DDrugs exempted from certain import provisions
Schedule E(i)Ayurvedic/Siddha/Unani poisonous substances
Schedule FBlood bank requirements
Schedule H / H1Prescription-only drugs
Schedule KDrugs exempted from certain Chapter IV requirements
Schedule TGMP requirements for ASU drug manufacturers
Schedule VStandards for patent and proprietary medicines
Schedule XHabit-forming/narcotic drugs

Summary: Why Chapter IV-A Matters

  1. Dedicated regulation - Creates a separate, tailored framework for traditional medicines rather than forcing them into modern pharmaceutical standards.
  2. Licensing control - Mandates manufacturing licences while protecting traditional practitioners (Vaidyas/Hakims) treating their own patients.
  3. Quality standards - Defines misbranding, adulteration, and spuriousness specifically for ASU drugs based on classical texts.
  4. Public safety powers - Gives the Central Government swift authority to ban dangerous or fraudulent products.
  5. Enforcement machinery - Separate Inspectors, Analysts, Advisory Board and Consultative Committee dedicated to the ASU sector.
This is a shared conversation. Sign in to Orris to start your own chat.